Kenvue Inc. (NYSE:KVUE) Shares Sold by Palouse Capital Management Inc.

Palouse Capital Management Inc. trimmed its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 23.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 110,613 shares of the company's stock after selling 34,677 shares during the quarter. Kenvue accounts for approximately 1.6% of Palouse Capital Management Inc.'s investment portfolio, making the stock its 27th biggest holding. Palouse Capital Management Inc.'s holdings in Kenvue were worth $2,362,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. AMF Tjanstepension AB boosted its stake in shares of Kenvue by 187.3% during the 3rd quarter. AMF Tjanstepension AB now owns 120,477 shares of the company's stock worth $2,787,000 after acquiring an additional 78,540 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in shares of Kenvue by 371.7% during the 3rd quarter. Exchange Traded Concepts LLC now owns 29,887 shares of the company's stock worth $691,000 after acquiring an additional 23,551 shares in the last quarter. Vontobel Holding Ltd. boosted its stake in shares of Kenvue by 13.4% during the 3rd quarter. Vontobel Holding Ltd. now owns 22,594 shares of the company's stock worth $523,000 after acquiring an additional 2,677 shares in the last quarter. AlphaMark Advisors LLC purchased a new stake in shares of Kenvue during the 3rd quarter worth about $77,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Kenvue by 1.8% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 198,300 shares of the company's stock worth $4,587,000 after acquiring an additional 3,428 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on KVUE shares. Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a "buy" rating to a "hold" rating and lowered their target price for the stock from $25.00 to $24.00 in a research note on Thursday, December 12th. Royal Bank of Canada restated a "sector perform" rating and set a $24.00 price target on shares of Kenvue in a research report on Monday, February 3rd. Barclays reduced their price target on shares of Kenvue from $23.00 to $21.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. Canaccord Genuity Group reduced their price target on shares of Kenvue from $27.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, February 7th. Finally, UBS Group reduced their price target on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $23.00.

Kenvue Trading Up 0.5 %

Shares of NYSE KVUE traded up $0.11 during midday trading on Thursday, reaching $22.38. 19,044,773 shares of the stock were exchanged, compared to its average volume of 13,433,218. The company has a 50 day simple moving average of $21.29 and a 200 day simple moving average of $22.14. The stock has a market capitalization of $42.90 billion, a P/E ratio of 42.22, a PEG ratio of 2.57 and a beta of 1.45. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, equities analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be given a $0.205 dividend. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 annualized dividend and a yield of 3.66%. Kenvue's dividend payout ratio is presently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.